FrontView REIT Q1 2026 Earnings EPS Surges Past Estimates with 174 Surprise Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress AMX Q1 2026 Earnings EPS Surpasses Expectations Amid Currency and Competition Challenges COFS Q1 2026 Earnings EPS Beats Estimates by 55 Amid Mixed Market Reaction VLRS Q1 2026 Earnings EPS Surpasses Estimates Despite Narrow Loss Chenghe Acquisition III Co CHEC Holds Steady at 1011 as SPAC Consolidates Near Trust Value EVT Edges Lower as TaxAdvantaged Dividend Fund Tests Neutral Territory Haoxi Health Technology HAO Plunges 20 Testing Critical Support at 083 Rayonier Advanced Materials RYAM Pushes Higher on Volume Key Levels to Watch Mattel Q1 2026 Earnings NarrowerThanExpected Loss Amid Cost Discipline